Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERO: Hydroxychloroquine PrEP for COVID-19 in HCWs
NCT04352946Phase 3Unknown
- Sponsor
- GeoSentinel Foundation
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by GeoSentinel Foundation. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04352946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352946.